Cargando…

Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone

Detalles Bibliográficos
Autores principales: Alter, Markus, Ott, Ina, von Websky, Karoline, Tsuprykov, Oleg, Sharkovska, Yuliya, Krause-Relle, Katharina, Raila, Jens, Henze, Andrea, Kretschmer, Axel, Stasch, Johannes-Peter, Hocher, Berthold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363201/
http://dx.doi.org/10.1186/1471-2210-11-S1-P1
_version_ 1782234315392811008
author Alter, Markus
Ott, Ina
von Websky, Karoline
Tsuprykov, Oleg
Sharkovska, Yuliya
Krause-Relle, Katharina
Raila, Jens
Henze, Andrea
Kretschmer, Axel
Stasch, Johannes-Peter
Hocher, Berthold
author_facet Alter, Markus
Ott, Ina
von Websky, Karoline
Tsuprykov, Oleg
Sharkovska, Yuliya
Krause-Relle, Katharina
Raila, Jens
Henze, Andrea
Kretschmer, Axel
Stasch, Johannes-Peter
Hocher, Berthold
author_sort Alter, Markus
collection PubMed
description
format Online
Article
Text
id pubmed-3363201
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33632012012-05-31 Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone Alter, Markus Ott, Ina von Websky, Karoline Tsuprykov, Oleg Sharkovska, Yuliya Krause-Relle, Katharina Raila, Jens Henze, Andrea Kretschmer, Axel Stasch, Johannes-Peter Hocher, Berthold BMC Pharmacol Poster Presentation BioMed Central 2011-08-01 /pmc/articles/PMC3363201/ http://dx.doi.org/10.1186/1471-2210-11-S1-P1 Text en Copyright ©2011 Alter et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Alter, Markus
Ott, Ina
von Websky, Karoline
Tsuprykov, Oleg
Sharkovska, Yuliya
Krause-Relle, Katharina
Raila, Jens
Henze, Andrea
Kretschmer, Axel
Stasch, Johannes-Peter
Hocher, Berthold
Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone
title Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone
title_full Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone
title_fullStr Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone
title_full_unstemmed Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone
title_short Additional stimulation of sGC on top of standard treatment with ARB`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to ARB treatment alone
title_sort additional stimulation of sgc on top of standard treatment with arb`s may offer a new therapeutic approach for the treatment of diabetic nephropathy resistant to arb treatment alone
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363201/
http://dx.doi.org/10.1186/1471-2210-11-S1-P1
work_keys_str_mv AT altermarkus additionalstimulationofsgcontopofstandardtreatmentwitharbsmayofferanewtherapeuticapproachforthetreatmentofdiabeticnephropathyresistanttoarbtreatmentalone
AT ottina additionalstimulationofsgcontopofstandardtreatmentwitharbsmayofferanewtherapeuticapproachforthetreatmentofdiabeticnephropathyresistanttoarbtreatmentalone
AT vonwebskykaroline additionalstimulationofsgcontopofstandardtreatmentwitharbsmayofferanewtherapeuticapproachforthetreatmentofdiabeticnephropathyresistanttoarbtreatmentalone
AT tsuprykovoleg additionalstimulationofsgcontopofstandardtreatmentwitharbsmayofferanewtherapeuticapproachforthetreatmentofdiabeticnephropathyresistanttoarbtreatmentalone
AT sharkovskayuliya additionalstimulationofsgcontopofstandardtreatmentwitharbsmayofferanewtherapeuticapproachforthetreatmentofdiabeticnephropathyresistanttoarbtreatmentalone
AT krauserellekatharina additionalstimulationofsgcontopofstandardtreatmentwitharbsmayofferanewtherapeuticapproachforthetreatmentofdiabeticnephropathyresistanttoarbtreatmentalone
AT railajens additionalstimulationofsgcontopofstandardtreatmentwitharbsmayofferanewtherapeuticapproachforthetreatmentofdiabeticnephropathyresistanttoarbtreatmentalone
AT henzeandrea additionalstimulationofsgcontopofstandardtreatmentwitharbsmayofferanewtherapeuticapproachforthetreatmentofdiabeticnephropathyresistanttoarbtreatmentalone
AT kretschmeraxel additionalstimulationofsgcontopofstandardtreatmentwitharbsmayofferanewtherapeuticapproachforthetreatmentofdiabeticnephropathyresistanttoarbtreatmentalone
AT staschjohannespeter additionalstimulationofsgcontopofstandardtreatmentwitharbsmayofferanewtherapeuticapproachforthetreatmentofdiabeticnephropathyresistanttoarbtreatmentalone
AT hocherberthold additionalstimulationofsgcontopofstandardtreatmentwitharbsmayofferanewtherapeuticapproachforthetreatmentofdiabeticnephropathyresistanttoarbtreatmentalone